19-55602182-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_153219.4(ZNF524):āc.70T>Cā(p.Ser24Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000808 in 1,608,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_153219.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF524 | NM_153219.4 | c.70T>C | p.Ser24Pro | missense_variant | 2/2 | ENST00000301073.4 | NP_694951.1 | |
ZNF524 | XM_011526487.3 | c.388T>C | p.Ser130Pro | missense_variant | 2/2 | XP_011524789.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF524 | ENST00000301073.4 | c.70T>C | p.Ser24Pro | missense_variant | 2/2 | 1 | NM_153219.4 | ENSP00000301073.2 | ||
ZNF524 | ENST00000591046.1 | c.70T>C | p.Ser24Pro | missense_variant | 1/1 | 6 | ENSP00000466907.1 | |||
ZNF524 | ENST00000589521.1 | c.70T>C | p.Ser24Pro | missense_variant | 2/2 | 3 | ENSP00000467175.1 |
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000143 AC: 35AN: 245094Hom.: 0 AF XY: 0.000135 AC XY: 18AN XY: 133072
GnomAD4 exome AF: 0.0000495 AC: 72AN: 1456008Hom.: 0 Cov.: 29 AF XY: 0.0000387 AC XY: 28AN XY: 724128
GnomAD4 genome AF: 0.000381 AC: 58AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.000349 AC XY: 26AN XY: 74464
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at